SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027929
Filing Date
2021-11-12
Accepted
2021-11-12 06:05:41
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 675178
2 ex31-1.htm EX-31.1 11588
3 ex31-2.htm EX-31.2 11655
4 ex32-1.htm EX-32.1 10709
5 form10-q_001.jpg GRAPHIC 88173
  Complete submission text file 0001493152-21-027929.txt   3982032

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20210930.xsd EX-101.SCH 37870
7 XBRL CALCULATION FILE pcsa-20210930_cal.xml EX-101.CAL 51845
8 XBRL DEFINITION FILE pcsa-20210930_def.xml EX-101.DEF 154263
9 XBRL LABEL FILE pcsa-20210930_lab.xml EX-101.LAB 283466
10 XBRL PRESENTATION FILE pcsa-20210930_pre.xml EX-101.PRE 241534
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 415901
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 211398924
SIC: 2834 Pharmaceutical Preparations